Article
Molecular epidemiology, cancer-related symptoms, and cytokines pathway.
The Lancet. Oncology - 1 Aug 2008
Reyes-Gibby Cielito C, Wu Xifeng, Spitz Margaret, Kurzrock Razelle, Fisch Michael, Bruera Eduardo, Shete Sanjay
Abstract excerpt
The Human Genome Project and HapMap have led to a better appreciation of the importance of common genetic variation in determining cancer risk, created potential for predicting response to therapy, and made possible the development of targeted prevention and therapeutic interventions. Advances in molecular epidemiology can be used to explore the role of genetic variation in modulating the risk for severe and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
